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Knowing the mutagenic and carcinogenic properties of chemicals is very important for their hazard (and risk) assessment. 
One of the crucial events that trigger genotoxic and sometimes carcinogenic effects is the forming of adducts between 
chemical compounds and nucleic acids and histones. This review takes a look at the mechanisms related to specific 
functional groups (structural alerts or toxicophores) that may trigger genotoxic or epigenetic effects in the cells. We 
present up-to-date information about defined structural alerts with their mechanisms and the software based on this 
knowledge (QSAR models and classification schemes).
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Carcinogenicity is an important toxicity endpoint in 
assessing chemical risk and hazards. The human population 
is exposed to various chemical agents that may promote 
one of the three stages of cancer development (initiation, 
promotion, progression) (1). Usually, the information about 
carcinogenic chemicals is gathered from animal or 
epidemiological studies (2). According to the mechanism 
of action carcinogens can be divided into two major groups: 
a) genotoxic carcinogens, which directly interact with and 
damage DNA by changing its structure and b) epigenetic 
carcinogens, which do not directly damage DNA (through 
covalent bonds) but affect its expression or make the cell 
more sensitive to other agents. Epigenetic carcinogens act 
in a wide range of mechanisms, while genotoxic carcinogens 
have a quite similar mode of action. These compounds are 
usually highly reactive electrophilic molecules that interact 
with the nucleophilic site in DNA. They can be electrophilic 
per se or metabolised to reactive electrophilic intermediates 
by several cellular processes (3, 4).
In the following sections we give an overview of some 
known mechanisms of carcinogenic action and of the 
software used to predict the mutagenicity and carcinogenicity 
of chemical compounds based on their structure. This 
software is a valuable tool in identifying and regulating 
potentially toxic chemicals.
With the efforts made to minimise animal testing (such 
as the EU ban to test animals for chemicals used in 
cosmetics industry), researchers have been looking for new, 
alternative methods to evaluate the toxic properties of 
molecules for specific endpoints such as carcinogenicity, 
mutagenicity, reproductive toxicity, developmental toxicity, 
skin sensitivity, and hepatotoxicity (2).
The review is intended to assist everyone involved in 
chemical regulation who intend to use in silico models for 
hazard communication, regulatory compliance, and 
sustainable lifecycle management.
CARCINOGENESIS
Carcinogenesis is the result of a number of complex, 
sequential processes within cells and tissues triggered by a 
variety of molecular and cellular changes. If induced by 
chemical compounds, carcinogenesis has three stages: 
initiation, promotion, and progression (Figure 1).
Carcinogenesis begins with a mutation, a stable, 
heritable change of a genetic material that has escaped DNA 
repair mechanisms during cell proliferation. In this initiation 
stage, mutations accumulate because they promote 
uncontrolled expression of proto-oncogenes, which control 
the cell cycle, including apoptosis and/or inactivation of 
tumour-suppressor genes (such as p53), which in turn 
encode enzymes for DNA damage repair. Initiation is a 
rapid, irreversible process in a number of mutational events 
triggered by chemical or physical agents (known as 
initiating agents or genotoxic agents).
The second stage is promotion. Under the influence of 
other endogenous or exogenous chemical compounds 
(growth stimuli) the initiated cells are subject to clonal 
growth, which promotes the tumour. This is why these 
exogenous and endogenous compounds are called tumour 
promoters. They are not mutagenic by themselves but 
trigger other mechanisms, such as changes in gene 
expression that are continued in all subsequent daughter 
Correspondence to: Professor Marija Sollner Dolenc, Ljubljana University 
Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Aškerčeva 
7, 1000 Ljubljana, Slovenia, E-mail: marija.sollner@ffa.uni-lj.si
170
cells. Cell proliferation rate increases and apoptotic cell 
death rate decreases. Promotion is a reversible process and 
only works in initiated cells. Well known promoters are 
phenobarbital, benzene, asbestos, and arsenic.
The last stage of carcinogenesis is progression, which 
involves additional genotoxic events (chromosomal 
aberrations and translocations). Progression is an irreversible 
process leading to the formation of neoplasms, benign and 
malignant alike (5-7).
Chemical carcinogens
Many genetic changes can occur spontaneously due to 
the presence of rare tautomers in nucleotide bases (keto/
enol form) and errors associated with the malfunctioning 
of DNA polymerases and oxidation of DNA induced by 
reactive oxygen species (ROS) because of respiratory chain 
and oxidative enzyme reactions (7). However, more and 
more studies claim that the large increase in cancer 
incidence is associated with exposure to chemical 
carcinogens or with factors such as age, diet, hormonal 
balance, or environment (8). About 80% of tumours in 
humans are triggered by exogenous chemical agents and 
are not necessarily associated with direct exposure to them 
but may also arise from normal metabolism, oxidative 
stress, or chronic inflammation. Chemical genotoxic 
carcinogens are divided into two main groups: direct-acting 
carcinogens and indirect-acting carcinogens. Direct-acting 
carcinogens cause cancer without metabolic activation or 
chemical modification (activation-independent), as they 
damage DNA from within. These chemicals are also known 
as parent compounds or ultimate carcinogens (9). The most 
common are epoxides, imines, and alkyl and sulphate esters. 
Indirect-acting carcinogens become carcinogenic after 
metabolic activation. Typical indirect carcinogens are 
polycyclic aromatic hydrocarbons (PAHs, benzo[a]pyrene 
in particular), nitrosamines, nitrosoureas, and aromatic 
amines (10-12).
Photogenotoxicity
One of the ways for chemical compounds to become 
genotoxic intermediates is through light activation 
(phototoxicity/photogenotoxicity). These compounds 
absorb light (UV, visible, and IR) and convert to another 
form (photomodification), degrade under the influence of 
light (photodegradation) (13), or reach an excited state 
(photoexcitation). Some compounds such as psoralens and 
phenothiazines affect DNA directly through photoexcitation, 
some such as porphyrins and riboflavins excite the 
surrounding molecules (such as chromophores), and some 
(such as furocumarin hydroperoxides and peroxy esters) 
react with DNA via ROS (14). Whichever the photogenotoxic 
mechanism, the compound must be excited close to the 
target (DNA) (13, 14).
The most common changes affecting DNA are 
pyrimidine dimers, covalent adducts, base modifications 
generated by oxidation, single-strand breaks, and base loss. 
Under the influence of light, polycyclic aromatic 
hydrocarbons (PAHs) tend to form adducts that covalently 
bind to DNA or cause DNA strand breaks (13). In these 
cases DNA repair mechanisms often fail, which can lead 
to photomutagenesis  or  even the ini t iat ion of 
photocarcinogenesis.  Photogenotoxicity can be 
experimentally studied with different techniques such as 
HPLC coupled with tandem mass spectrophotometry 
(HPLC/MS-MS) or HPLC coupled with an electrochemical 
detector (HPLC/ECD) combined with the in vitro Comet 
assay or similar in vitro methods (15).
Electrophiles as carcinogens
In their ultimate form, direct or indirect-acting chemical 
carcinogens (after metabolic activation) work as reactive 
electrophiles (11). These compounds form covalent adducts 
with most of the cellular informational macromolecules 
(nucleophiles) such as DNA, RNA, or proteins. Nucleophiles 
contain nucleophilic sites that typically include electron-
rich (unpaired electrons) heteroatoms such as S (side chain 
of cysteine residues - thiol groups, S-atoms of methionine), 
O (alcohol group of the phenolic amino acid of tyrosine, 
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Figure 1 Multistage carcinogenesis (3)
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Electrophilic chemical reaction mechanisms forming 
adducts with DNA
The understanding of the mechanisms of action through 
which electrophiles react with biological nucleophiles is 
based on the classical chemical reactions: conjugation, 
substitution, and addition, in which the electron-rich 
component interacts with the electron-deficient one (29). 
We know of about fifty mechanisms of covalent binding, 
but only six can lead to cancer: SN, SN2, acylation, Schiff 
base formation, Michael addition, and SNAr (Figure 3). 
These mechanisms enable us to classify different 
electrophiles into appropriate mechanistic domain (Table 
1)(30). SN1 is a first-order, two-stage nucleophilic 
substitution. In the first stage, the leaving group is branched 
off, and in the second stage, the resulting carbenium ion 
reacts with a nucleophile. SN2 is a second-order nucleophilic 
substitution where the leaving group disconnects and attacks 
a nucleophile in a single step (31). Acylation is a reaction 
where reactive tetrahedral intermediate is formed with a 
nucleophile, and the leaving group is released. Schiff base 
formation is a mechanism where electrophilic carbon atoms 
of aldehydes or ketones are attacked by amines and the C=O 
double bond is replaced by the C=N double bond (32). 
Michael addition is a two-step nucleophilic addition, where 
nucleophile attacks a double bond and forms two new 
bonds. SNAr is electrophilic aromatic substitution in which 
nucleophile attacks the leaving group and the aromatic 
structure stays unchanged (33, 34).
Consequences of endogenous DNA adduct formation
DNA adducts may trigger different structural changes 
in genetic material (1, 3, 12). Different chemicals react with 
different DNA bases on different DNA positions (4). The 
most common types of damage caused by DNA adducts are 
base oxidation, ethenobases, alkylation (usually 
methylation), and base hydrolysis (deamination or 
depurination). In deamination ammonia is released, and 
cytosine (adenine) is transformed into uracil (hypoxanthine), 
which causes the binding of adenine (cytosine) instead of 
guanine (thymine) when DNA is replicated. Depurination 
is the cleaving of the N-glycoside bond between the purine 
base and deoxyribose in DNA, leading to the formation of 
an apurinic site and structural change. Depurination of bases 
on a single-stranded DNA during replication can lead to 
mutation, because an incorrect base is added to the apurinic 
site (35). This can lead to transversion or transition (36). 
Electrophilic PAH metabolites are well-known examples 
of adducts that promote depurination. They are also capable 
of forming bulky DNA adducts. These PAH-DNA adducts 
can trigger nucleotide excision repair or affect important 
regulatory genes such as Ras and p53 (37, 38). Bulky 
adducts can form a stable intercalation between the bases. 
Intercalators are planar molecules that intercalate between 
the base pairs in the double-stranded DNA. Intercalation 
changes the shape of the double helix and can cause 
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serine, and threonine residues), and N (primary amino-
groups of lysine or arginine, secondary amino-group of 
histidine) (16). The most vulnerable cellular nucleophiles 
are nucleic acids, DNA bases guanine, adenine, cytosine, 
and thymine in particular. The most vulnerable to adduct 
forming are the following base sites: N1, N3, and N7 of 
adenine, N2, N7, and O6 of guanine, N3 and O2 of cytosine, 
and N3, O2, and O4 of thymine (17, 18). The most common 
reaction between electrophiles and nucleophiles is 
alkylation, especially of purine at the N7 site of guanine. 
Alkylation may also occur at the O6 site of guanine and 
other bases, but more slowly. The O6 site is important for 
mutagenicity. The newly formed ether covalent bond is 
known to change the electronic distribution around the base, 
which leads to deprotonation at site N1. This changes the 
pattern of hydrogen bonds and causes misconnections 
between the bases (16, 19). The targets of alkylation are 
not only nitrogen bases but also phosphodiester bonds 
(phosphate alkylation).
Each carcinogenic electrophile has a specific activation 
target, specific metabolism, and specific binding site on the 
nucleophile. Strong electrophiles are small, poorly polarised 
molecules, and their electron deficiency shows as positive 
electron charge. Soft electrophiles are usually large, highly 
polarised molecules, and their electron deficiency spreads 
all over the molecule (20, 21). Strong (hard reactive) 
electrophiles include nitroso compounds, epoxides, α,β-
unsaturated aledhydes, N-sulphonyloxy-N-methyl-4-
aminoazobenzene,  N-sulphonyloxy-N-acetyl-2-
aminofluorene, and N-hydroxy-2-aminofluorene. Soft 
electrophiles include safrole, estragole, N-methylol-4 
aminoazobenzene (17, 22).
Another important chemical event in neoplasm 
formation is the hydroxylation of DNA bases as a result of 
interaction between a hydroxyl radical (OH.) and base. The 
resulting products include 8-hydroxyguanine (8-OH-dG), 
8-hydroxyadenine (8-OH-dA), 5-hydroxyuracil (5-OH-dU), 
5-hydroxycytosine (5-OH-dC), thymine glycol, and uracil 
glycol (23).
Structural alerts for genotoxicity
In 1985, John Ashby introduced structural alerts as a 
way to predict genotoxicity (Figure 2) (1). Benigni and 
Bossa (24) summarised structural alerts as follows: “The 
Structural Alerts are molecular substructures or reactive 
groups that are related to the carcinogenic and mutagenic 
properties of the chemicals, and represent a sort of 
'codification' of a long series of studies aimed at highlighting 
the mechanisms of action of the mutagenic and carcinogenic 
chemicals”. Structural alerts are very helpful not only in 
the classification of potential carcinogens, but are also 
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S- or N-mustards
       
or




                    R=[Br, Cl, F, I]
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Figure 2 Upgrade of Ashby's structural alerts with genotoxic potential and their examples (1, 2, 24-28)
mutations (insertions and deletions), block replication and 
transcription, or affect DNA repair mechanisms (39).
All of these events can lead to DNA base changes 
(5-hydroxyuracil, 5-hydroxycytosine, 7,8-dihydro-8-
oxoguanine, 7,8-dihydro-8-oxoadenine, 2,6-diamino-4-
h y d r o x y - 5 - f o r m a m i d o p y r i m i d i n e ,  o r 
5-hydroxypyrimidines), base loss, base substitutions 
(mostly G>T transversions), frameshift mutations, insertion, 
sequence amplification, generation of single- and double-
strand breaks, sister chromatid exchanges, DNA-protein 
cross-links, and pyrimidine dimer formations (40-45).
Epigenetic mechanisms of carcinogenic molecules
Exposure to some chemical carcinogens may cause 
cancer without changes in the nucleotide sequences. 
Epigenetic factors are common in cells that are constantly 
under stress. Such chemicals do not form DNA adducts nor 
do they alter DNA but affect the expression of certain genes 
(28). All epigenetic factors (physical, chemical, and 
biological) mainly operate in two ways: either via 
methylation or via post-translational modifications of 
histones (acetylation). DNA methylation occurs at the 
promoter region, which contains CpG islands (cytosine and 
guanine nucleotides linked with a phosphodiester bond) 
(46) and results in the conversion of cytosine to 
5-methylcytosine, which has a much higher mutagenic 
potential. There are two mechanisms of methylation: 
hypermethylation and hypomethylation. Hypermethylation 
usually occurs at CpG islands and may affect genes involved 
in the cell cycle, DNA repair mechanisms, intercellular 
interactions, and apoptosis. Hypermethylation may also 
increase deamination of 5-methylcytosine to thymine, 
leading to C to T conversion. In contrast, hypomethylation 
at CpG sites may lead to the overexpression of oncogenes, 
chromosome instability, and metastases (47).
Acetylation of histones is regulated by histone acetyl 
transferases (HATs), which play an important role in 
chromatin transformation and in the regulation of gene 
transcription (48). Acetylation of lysine residues neutralises 
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histones in the nucleosome and thus reduces their affinity 
to negatively charged DNA. Reduced affinity leads to the 
decondensation of DNA and eventually to transcription 
(49). Histone acetylation does not affect histone affinity to 
DNA alone but also affects the interaction between histones 
and histone interaction with other regulatory proteins. In 
other words, histone acetylation may affect processes such 
as replication, formation of nucleosomes, and chromatin 
packaging (50).
Cell exposure to oxidative stress and DNA damage
When we are talking about chemical carcinogenesis we 
cannot skip oxidative stress caused by reactive oxygen/
nitrogen species (ROS/RNS) (46). The reactive species 
most often involved in carcinogenesis are superoxide anion 
radical O2
.-, hydroxyl radical (HO.), nitric oxide (NO), 
nitrous acid (HNO2), peroxynitrite (ONOO
−), hydroperoxyl 
radical (HO2
.), ozone (O3), and hydrogen peroxide (H2O2). 
These compounds can be generated by inflammation, 
radiation, interruption of mitochondrial oxidative 
phosphorylation, or xenobiotic metabolism, but most of 
them are generated by redox cycling induced by chemical 
carcinogens that contain structural alerts, such as 
halogenated compounds, aromatic hydrocarbons, aromatic 
N-oxides, quinones, aromatic nitro compounds, conjugated 
imines, heterocyclic amines, and pyridyl compounds (5, 
30). Oxidative stress arises when the redox balance is 
disrupted and the number of ROS/RNS exceeds the number 
of natural cell defence molecules (antioxidants), which leads 
to DNA, protein, and lipid damage (51). Directly acting 
oxidative stress can cause structural DNA changes such as 
base pair substitution, deletion, insertion, base oxidation, 
guanine-to-cytosine or thymine-to-adenine transversion, 
double- or single strand-breaks, deamination of guanine 
and adenine, nitration of guanine, or modification of purine/
pyrimidine nucleosides (30). Indirectly acting oxidative 
stress can change the membrane, cytoplasmic, and nuclear 
signal transduction pathways, modulate genes that increase 
cell proliferation or differentiation, and inhibit programmed 
cell death (apoptosis). Not only can ROS generate mutations 
but can also interfere with DNA repair (4).
The role or endocrine disruptors in carcinogenicity
In recent years the role of endocrine disruptors in 
carcinogenesis has received a lot of attention. Endocrine 
disrupting chemicals (EDC) can interfere with and affect 
the endocrine system, which can lead to hormone-related 
cancers (breast, testicular, prostate, or leukaemia). The main 
mechanism of EDC action is that they bind to the active 
sites of oestrogen, androgen, and thyroid receptors (52). 
They can trigger the same response as natural hormones, 
agonistic or antagonistic alike. Ligand-receptor interactions 
most often result in changes in the transcription genes (53), 
which, in turn, changes cell activities such as regulation/
stimulation of cell proliferation, regulation of gene 
expression, gene signalling, and hormone metabolism, 
biosynthesis, bioactivation, and degradation. Changes in 
hormonal levels affect DNA methylation, histone 
modifications, or apoptosis (54). EDCs show some 
structural similarity to non-genotoxic compounds such as 
phenolic compounds, PAHs, isoflavonoids, stilbenes, and 
compounds with steroid structure (54-56).
Other factors determining the carcinogenic potential of 
chemical compounds
Carcinogenicity and mutagenicity are not related only 
to structural alerts. Certain compounds may contain all of 
the structural alerts, but are not metabolically active inside 
the cell. Among the physiochemical factors that may hinder 
the functioning of these toxic molecules are: i) molecular 
weight and the size of chemicals: the higher the molecular 
weight of compounds, the lesser the chance they will be 
absorbed in significant amounts; ii) state of matter: affects 
the ability of a compound to reach the critical point; iii) 
solubility: highly hydrophilic compounds are poorly 
absorbed by the cell membrane, and, if absorbed, readily 
excreted; iv) geometry of chemicals: planar shape of a 
molecule has the highest carcinogenic potential; and v) 
chemical reactivity: chemicals that are highly reactive have 
lower toxic potential because they hydrolyse or polymerise 
spontaneously or react with non-critical cellular components 
before they reach the target (29). Other factors include the 
stability of a compound, transport through the membrane, 
and half-life (2, 57).
Software packages for mutagenicity and carcinogenicity 
predictions
Due to ethical reasons, reduced resources, and time 
savings, toxicity testing of chemicals in animals is getting 
more and more restrictive. This is why chemical and related 
industries have started to adopt the “3R” (replacement, 
reduction, and refinement) principle. Two major alternatives 
to in vivo animal testing are in vitro techniques and in silico 
computer simulation.
In the last decade, a number of computer programs have 
been developed to assess the mutagenicity and 
carcinogenicity based solely on chemical structures as input. 
Below we present some of the most common software 
packages for predicting mutagenicity and carcinogenicity 
of chemical compounds.
VEGA platform and CAESAR
The VEGA platform serves to access a number of QSAR 
models for predicting mutagenicity and carcinogenicity 
such as the Computer-Assisted Evaluation of Industrial 
Chemical Substances According to Regulation (CAESAR). 
CAESAR is a software tool which was specifically 
dedicated to develop QSAR mutagenicity models for the 
Registration, Evaluation, Authorisation and Restriction of 
Chemicals (REACH) regulation in collaboration with the 
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United States Environmental Protection Agency (more 
information is available at: http://www.caesar-project.eu/). 
Models for predicting mutagenicity are based on a set of 
4225 molecules tested with the Ames bacterial test. Models 
for carcinogenicity were built on a set of 805 chemicals 
from the Carcinogenic Potency Database (CPDBAS) (58). 
CAESAR meets all five principles of the Organisation for 
Economic Co-operation and Development (OECD). It has 
good predictive capabilities for mutagenicity and 
carcinogenicity but, unfortunately, it does not include 
prediction models for genotoxicity (59).
DEREK
The Deductive Estimation of Risk from Existing 
Knowledge (DEREK), developed by LHASA Limited, 
(Leeds, Great Britain) is a software package that predicts 
whether a particular substance triggers toxic response based 
on structural similarity with known toxic compounds and 
their structural alerts associated with specific endpoints 
(genotoxicity, mutagenicity, and carcinogenicity). DEREK 
contains over 75 rules for the Ames mutagenicity endpoint 
predictions, which are based on empirical relationships and 
mechanisms of action. The model includes 89 structural 
alerts for mutagenicity, 77 for chromosome aberrations, and 
91 for carcinogenicity. Structural alerts causing genotoxicity 
are composed of mutagenicity and structural alerts based 
on data from several in vitro and in vivo mutagenicity tests 
and other genotoxicity data. The software was developed 
for research and industry users in collaboration with 
industry, academia, and regulatory authorities (2, 60).
TOPKAT
The Toxicity Predictions by Komputer Assisted 
Technology (TOPKAT) is an expert system developed by 
Accelrys, Inc. (now Biovia, San Diego, CA, USA). Unlike 
the two above mentioned software tools, TOPKAT is 
entirely based on two-dimensional electrotopological 
descriptors but it also relies on the QSAR model. TOPKAT 
can predict a wide range of toxicological endpoints, 
including mutagenicity and carcinogenicity. The results of 
the program are given numerically (0 - inactive compound; 
1 - active compound) based on structural similarity with 
known toxic and nontoxic compounds. Mutagenicity and 
carcinogenicity models include data derived from bacterial 
mutagenicity and rodent carcinogenicity tests. The 
mutagenicity model is based on data for 393 chemicals from 
the US EPA GeneTox protocol (60).
MultiCASE
This expert system is based on the US FDA and EPA 
for genotoxicity and carcinogenicity endpoints (MultiCASE 
Inc., Cleveland, OH, USA). It is often used for pharmaceutical 
toxicity screening of drug candidates with potential for 
development. It automatically identifies structural alerts 
with a potential to initiate high biological activity (toxic 
response) and analyses statistical parameters to get the final 
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Table 1 Structural alerts which belong to certain mechanistic domain (30, 32, 33)
Mechanistic domain Structural alerts
SN2










Alkyl and aryl N-nitroso groups
Aliphatic N-nitro group
Aromatic nitroso group
Aromatic amines and hydroxylamine
Halogenated polycyclic aromatic hydrocarbon (PAH)
Halogenated dibenzodioxins
Acylation Aromatic diazo groupsAcyl halides




Aromatic mono- and dialkylamino groups
Halogenated benzene
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predictions. Its mutagenicity and genotoxicity models are 
based on the Ames mutagenicity, direct mutagenicity, base-
pair mutagenicity, frameshift mutagenicity, chromosomal 
aberrations, and sister chromatid exchange data. The 
carcinogenicity model includes different rodent assays (rate, 
mouse, male, female, and TD50 rats) and human epigenetic 
studies. All models use the statistical approach with the 
exception of the rule-based model for the Ames mutagenicity. 
The models are developed according to the OECD rules, the 
ICH M7 guidelines for impurities in pharmaceuticals, and 
the REACH guidelines, and therefore targets pharmaceutical 
and chemical industry in particular (2, 61, 62).
Another approach for detecting genotoxic compounds 
that covalently bind to DNA are tools that group similar 
chemicals into appropriate classes, according to the same 
structural alerts. Below we present some of the tools that 
are based on these principles.
QSAR Toolbox
QSAR TOOLBOX is a software application for 
grouping chemicals into categories and assessing the 
potential adverse effects of chemicals in cooperation with 
the European Chemical Agency (ECHA), according to 
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Figure 3 Mechanisms of covalent binding to cellular nucleophiles (DNA, proteins)
*Nu- nucleophilic site of molecule
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OECD principles (more information is available at: http://
www.qsartoolbox.org/). It is intended for government 
agencies, chemical industry, and public organisations to 
provide missing (eco)toxicological information necessary 
to assess chemical hazard. The QSAR Toolbox systematically 
groups chemicals into categories according to their 
structural, physicochemical, and toxicological properties. 
The program identifies structural characteristics and modes 
of action for a specific target based on experimental 
information. It allows quick evaluation of chemicals for 
common mechanisms or modes of action as well as for 
common toxicological behaviour or consistent trends 
among results related to regulatory endpoints. The 
experimental information has been pooled from three 
databases: ISSSTY (bacterial mutagenicity database), 
CPDB (Carcinogenici ty Potency Database for 
carcinogenicity), and ISSCAN (carcinogenicity and 
mutagenicity database (57, 61, 63).
Toxtree
Toxtree is a user-friendly, open-source application that 
predicts various kinds of toxic effects using decision trees 
to place chemicals into appropriate categories. It estimates 
mutagenicity and carcinogenicity potentials based on the 
Benigni-Bossa rules for mutagenicity and carcinogenicity, 
structural alerts for identification of Michael acceptors, and 
structural alerts confirmed by positive in vivo micronucleus 
tests. If a structural alert is present in the molecule, the 
program recognises the mutagenic and carcinogenic 
potential of the compound. Input can be entered using the 
simplified molecular-input line-entry system (SMILES) or 
2D structure. The results are colour-coded: green highlight 
for class I - inactive, yellow highlight for class II - weak 
activity, and red highlight for class III - active. The program 
was developed by Ideaconsult Ltd. (Sofia, Bulgaria), for 
researchers and other stakeholders (especially industry) (1, 
61, 64).
LAZAR
Lazy Structure-Activity Relationships (LAZAR) is an 
open-source tool for the prediction of complex toxicological 
endpoints such as carcinogenicity (female/male, hamster/
mouse/rat/rodent) and Salmonella mutagenicity. Unlike 
other software, LAZAR creates local endpoint QSAR 
models based on a training set (only nearest neighbours) 
for each compound separately. It first calculates the 
molecular descriptors and determines chemical similarity 
(alerts and compounds) and then it builds a local QSAR 
model based on a database of experimental toxicity data. 
Carcinogenicity models are based on CPDB, while the 
Salmonella mutagenicity model uses a dataset of 3895 
compounds determined in vitro. This program meets all five 
OECD principles (65, 66).
ACD/Tox Suite
This industry-leading software package was developed 
to predict various toxicity endpoints such as genotoxicity, 
carcinogenicity, cytochrome P450 (CYP3A4) inhibition, 
oestrogen receptor (ER) binding affinity, irritation, rodent 
acute lethal toxicity (LD50), aquatic toxicity, and organ-
specific health effects. The predictions are made on the basis 
of validated QSAR models in combination with expert 
knowledge of organic chemistry and toxicology. It is 
primarily intended for ICH M7 submissions in 
pharmaceutical industry. The software can determine and 
visualise which parts of molecules, i.e., structural alerts 
(toxicophores) are responsible for toxic responses and can 
identify analogues from the training set. The training set is 
based on compounds that are genotoxic in the Ames test 
and are taken from the Chemical Carcinogenesis Research 
Information (CCRIS) and Genetic Toxicology Data Bank 
(GENE-TOX). Input can be entered as a 2D structure or a 
SMILES string, and the program yields predictions and up 
to five similar compounds from the training set (67).
Leadscope Model Applier
The Model Applier developed by Leadscope, Inc. 
(Columbus, OH, USA) uses QSAR models for the following 
endpoints: Salmonella mutagenicity, E. coli mutagenicity, 
mouse lymphoma, in vitro chromosome aberrations, and in 
vivo micronuclei. It was developed according to the ICH 
M7 guideline for impurities and is basically intended for 
the pharmaceutical industry (68).
CONCLUSION
In silico methods have become an acceptable alternative 
to animal testing to fill data gaps and improve the 
management of chemicals (e.g. the UN Globally Harmonized 
System of Classification and Labelling of Chemicals, GHS). 
They are run to submit data for regulatory purposes (e. g. 
REACH) and to obtain marketing authorisation for 
pharmaceuticals. In the past decade, several software 
applications have been designed to use data systems 
involving molecular descriptors specific to toxic endpoints 
and reference databases with the aim to predict the 
properties of new compounds.
All studies so far have shown that mutagenicity and 
carcinogenicity are parallel, although carcinogenicity is 
much more complex than mutagenicity. Understanding the 
mechanisms of covalent binding of chemicals with 
nucleophilic cellular targets enable us to group chemical 
compounds with similar mechanisms of action and similar 
toxic (mutagenic and carcinogenic) effects on the cell (11). 
Knowledge of the interconnections between the structure 
and mechanisms of action of potentially carcinogenic 
compounds helps us to understand these events.
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Mehanizmi delovanja tveganih kemijskih struktur za mutagenost in kancerogenost
Poznavanje mutagenih in rakotvornih lastnosti kemikalij je zelo pomembno za njihovo oceno tveganja in nevarnosti. 
Eden od ključnih dogodkov, ki sprožijo genotoksični in včasih kancerogeni učinkek je tvorba aduktov med kemikalijami 
in nukleinskimi kislinami ter histoni. Ta članek povzema pregled mehanizmov povezanih s specifičnimi funkcionalnimi 
skupinami (strukturnimi alerti ali tveganimi kemijskimi strukturami), ki lahko sprožijo genotoksične ali epigenetske 
učinke v celicah. Predstavlja aktualne informacije o poznanih strukturnih alertih, njihove mehanizme interakcij z genetskim 
materialom in programsko opremo, ki na osnovi  poznavanja teh mehanizmov z uporabo QSAR modelov in klasifikacijskih 
shem omogočajo napovedovanje genostoksičnosti še nepoznanih kemikalij.
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